Skip to main content.

Andreas Schmid, M.D.

Andreas Schmid portrait
Associate Professor, Pulmonary, Critical Care and Sleep Medicine
aschmid@kumc.edu

Professional Background

Dr. Andreas Schmid is an Associate Professor of Medicine at the University of Kansas Medical Center. He is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine through the American Board of Internal Medicine.

Before becoming a physician, Dr. Schmid studied architecture at the Swiss Technical University in Zürich, Switzerland. Soon after, he enrolled and completed medical school and residency in Internal Medicine at several Swiss hospitals including the University of Basel.

In 2003, Dr. Schmid moved to Florida and completed Pulmonary and Critical Care Fellowship training, and Internal Medicine Residency, at Jackson Memorial Hospital in Miami, Florida.

Since 2018, he works at the University of Kansas Medical Center where he is active in the ICU, inpatient consult and the outpatient clinic setting. He has a clinical interest in Non-CF bronchiectasis, and non-tuberculous mycobacteria.

Education and Training
  • MD, Medicine, University of Basel, Switzerland
Licensure, Accreditations & Certifications
  • Doctor of Medicine, Florida Board of Medicine
  • Doctor of Medicine, Kansas Board of Healing Arts

Selected Publications
  • Mirsaeidi M, Vu A, Leitman P, Sharifi A, Wisliceny S, Leitman A, Schmid A, Campos M, Falkinham J, Salathe M. 2017. A Patient-Based Analysis of the Geographic Distribution of Mycobacterium avium complex, Mycobacterium abscessus, and Mycobacterium kansasii Infections in the United States.. Chest, 151 (4), 947-950
  • Schmid A, Sailland J, Novak L, Baumlin N, Fregien N, Salathe M. 2017. Modulation of Wnt signaling is essential for the differentiation of ciliated epithelial cells in human airways.. FEBS letters, 591 (21), 3493-3506
  • Paredes Aller S, Quittner AL, Salathe MA, Schmid A. 2018. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.. Expert review of respiratory medicine, 12 (9), 769-782
  • Eden E, Choate R, Barker A, Addrizzo-Harris D, Aksamit TR, Daley CL, Daniels MLA, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Turino GM, Winthrop KL. 2019. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.. Chronic obstructive pulmonary diseases (Miami, Fla.), 6 (2), 145-153
  • Basavaraj A, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Daley CL, Anne Daniels ML, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL. 2020. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry.. Chest, 158 (4), 1376-1384
  • Choate R, Aksamit TR, Mannino D, Addrizzo-Harris D, Barker A, Basavaraj A, Daley CL, Daniels MLA, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, McShane PJ, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Stone G. 2020. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.. Respiratory medicine, 177, 106285
  • Despotes KA, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Basavaraj A, Daley CL, Eden E, DiMango A, Fennelly K, Philley J, Johnson MM, McShane PJ, Metersky ML, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Knowles MR, Daniels MLA, Noone PG. 2020. Nutrition and Markers of Disease Severity in Patients With Bronchiectasis.. Chronic obstructive pulmonary diseases (Miami, Fla.), 7 (4), 390-403
  • Kim MD, Baumlin N, Dennis JS, Yoshida M, Kis A, Aguiar C, Schmid A, Mendes E, Salathe M. 2021. Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion.. ERJ open research, 7 (1)